Drug Therapy

Top 25 orphan drugs, by 2015 global sales

Top 25 orphan drugs, by 2015 global sales

Roche's Rituxan generated $7.3 billion in sales in 2015, making it the top-selling orphan drug.

Patients expect pharma will boost engagement

Patients expect pharma will boost engagement

By

The pharma business needs to take engagement far more seriously than it has in the past. At the same time, there are signs that the industry is finally acting with more urgency and even transparency.

Study: Patients with marketplace health plans spend less on medications

Study: Patients with marketplace health plans spend less on medications

By

Employer-insured enrollees spend more on prescriptions than health-insurance exchange enrollees, but the groups spend the same amount of money when it comes to specialty medications, a study shows.

Five things for pharma marketers to know: Friday, May 22

Five things for pharma marketers to know: Friday, May 22

By

Amgen's PSCK9 inhibitor gets a position opinion in the EU; the FDA plans to study how spouses influence perception of DTC ads; Botox may relieve depression

 Strategies to Increase the Value of Drug Therapy

Strategies to Increase the Value of Drug Therapy

Value is a concept that concerns all healthcare stakeholders.

OPINION

Email Newsletters